| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |